An international research project was launched in 2017 to study the use of biological markers in estimating radiation exposure for patients undergoing various medical procedures. The project, coordinated by the International Atomic Energy Agency (IAEA), involves institutions from 31 countries worldwide.
Radiation Exposure Assessment Research Project
The IAEA’s coordinated research project, known as MEDBIODOSE, examines the role of biodosimetric markers and methods within radiation oncology, nuclear medicine, and diagnostic and interventional radiology. Thirty-one institutions joined the project from Argentina, Australia, Brazil, Canada, Chile, China, Cuba, France, Ghana, India, Indonesia, Israel, Japan, Lithuania, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Slovakia, South Africa, Sudan, Thailand, Ukraine, United Kingdom, Uruguay and Viet Nam.
Each participating team collected and analyzed patients’ biodosimetric data, which includes biological measurements used to estimate radiation exposure. This data encompasses cytogenetic information – specifically chromosomal aberrations – and molecular data, including protein markers associated with damaged DNA and changes in gene expression.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
